Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS
about
Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cellsLipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranesLow-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infectionsThe BPI/LBP family of proteins: a structural analysis of conserved regionsSignificance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patientsConventional, molecular methods and biomarkers molecules in detection of septicemiaDiagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-AnalysisInactivation of staphylococcal phenol soluble modulins by serum lipoprotein particlesHigh-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung DiseaseProduction of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxinsLipopolysaccharide (LPS)-binding protein inhibits responses to cell-bound LPSThe carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexesPlasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteinsMembrane Insertion for the Detection of Lipopolysaccharides: Exploring the Dynamics of Amphiphile-in-Lipid AssaysCollagen-like proteins of pathogenic streptococciConstruction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions.Apheresis of plasma compounds as a therapeutic principle in severe sepsis and multiorgan dysfunction syndrome.The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis.Of microbes and meals: the health consequences of dietary endotoxemia.Lipopolysaccharide and its analog antagonists display differential serum factor dependencies for induction of cytokine genes in murine macrophages.Low HDL levels in sepsis versus trauma patients in intensive care unit.Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice.Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier.LBP and sCD14 patterns in total hip replacement surgery performed during combined spinal/epidural anaesthesia.Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemiaChanges in endotoxin-binding proteins during major elective surgery: important role for soluble CD14 in regulation of biological activity of systemic endotoxinSoluble mediators regulating immunity in early lifeCirculating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance.New approaches to sepsis: molecular diagnostics and biomarkers.Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE)Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activation.5A, an apolipoprotein A-I mimetic peptide, attenuates the induction of house dust mite-induced asthmaLipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation.Novel therapies for sepsis: antiendotoxin therapies.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Directed evolution of an LBP/CD14 inhibitory peptide and its anti-endotoxin activityAssociation of the CD14 gene -159C polymorphism with progression of IgA nephropathy.Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxinIntravaginal lactic Acid bacteria modulated local and systemic immune responses and lowered the incidence of uterine infections in periparturient dairy cowsEffect of anticoagulants on binding and neutralization of lipopolysaccharide by the peptide immunoglobulin conjugate CAP18(106-138)-immunoglobulin G in whole blood
P2860
Q24514488-7126B996-D4CC-425E-A9CB-63D0A428767EQ24548769-E0DDA4D1-F799-44E1-BF6F-F522ACCC3633Q24562428-A583D2FB-AA98-46D9-BD15-10EBE56C1AE2Q24673162-358A1D18-9216-49C9-8BFA-36116F735E95Q24802392-CC72A7FD-4C90-4C47-AC05-CC566DE4B084Q26799362-22C053E4-AD40-47E0-ADD8-711CB7529200Q27026668-125C96B7-A49D-4394-BB5D-39207A01A4B3Q27346660-B01AD905-9AF6-4FAE-BF2F-92D5F01F5647Q28075541-B13B7171-D21B-4440-BFE8-0A4857B3B3F8Q28142299-950AFCD3-A424-4242-A29F-01F558CDDB0FQ28204864-5D5EAC72-2831-489C-B7C8-D617777EACF5Q28214380-F5E0E547-3882-4E1C-B0FB-37ED6C083006Q28282116-3F1F0B08-17EC-478F-8AF4-62EB869CDEACQ28552464-6D896B2E-64C9-4CD0-9674-ABCAB531B20EQ29248479-B14D74FA-067F-4A36-AFDA-6458F25FFAA5Q31577999-82346A40-7EF3-4C5B-BB36-4DDC5126AF5CQ33649871-EE53780B-2173-4D15-8AD5-C1F5DF493504Q33653635-CD17D210-87EE-435E-B13A-86D9FB51374CQ33713662-D24A4AEF-7196-4470-B94F-FD38DB986427Q33754384-454F3370-A1D6-4064-B676-E66DCD82CF72Q33770014-6DDDB9CF-B7E4-4F15-B3CA-867ABF8EAD18Q33882880-E3EF8672-4EFC-4B1C-97CD-29E0558DF333Q33898454-FA56C374-AD53-47BC-8CBB-79D97BCE8271Q33948601-89EF9680-D65C-4827-8F04-914CBB8FC6C8Q33997331-F2DFA905-FF16-403A-94CD-3D55C6791B97Q33997983-F82879E8-E251-4D72-9202-D34E0863E511Q34238426-0B015AFD-3C01-4E02-9A32-11F5C5D9E500Q34241743-5138D0D7-2A3A-423C-9055-FF15FFCC5A79Q34303687-18AC9686-4057-4851-82CC-3BD210CDE8C1Q34323715-108C13EC-8A7B-41C5-BB01-AE5ED2907FBBQ34427028-3747B8A9-A7D5-4B0B-82F0-30F511869C7FQ34449116-9AA80A8A-A7B8-469C-8E40-010F11E74479Q34744890-82F39E47-6326-43AC-AE91-C1DB14C407FCQ35011910-F20BA57F-3973-4CAC-A84D-BE769C9190D2Q35176262-562E2EFC-0331-4736-9F6B-32B8DDA96A65Q35207052-3B06677A-10DB-4B6A-AACD-E404AAE8D932Q35441532-B4482325-176D-48F8-A0E2-43A5037423B1Q35516570-5EDF7D24-3A5E-4A7F-B96C-03D44B9E98DEQ35546593-F353DAB2-E0C1-4369-8558-C81E84DA35DFQ35548846-4E01F2AB-680A-4525-8E46-F4F55A7171AB
P2860
Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Lipopolysaccharide (LPS)-bindi ...... r in the neutralization of LPS
@ast
Lipopolysaccharide (LPS)-bindi ...... r in the neutralization of LPS
@en
type
label
Lipopolysaccharide (LPS)-bindi ...... r in the neutralization of LPS
@ast
Lipopolysaccharide (LPS)-bindi ...... r in the neutralization of LPS
@en
prefLabel
Lipopolysaccharide (LPS)-bindi ...... r in the neutralization of LPS
@ast
Lipopolysaccharide (LPS)-bindi ...... r in the neutralization of LPS
@en
P2093
P2860
P356
P1476
Lipopolysaccharide (LPS)-bindi ...... r in the neutralization of LPS
@en
P2093
H Lichenstein
M M Wurfel
S D Wright
S T Kunitake
P2860
P304
P356
10.1084/JEM.180.3.1025
P407
P577
1994-09-01T00:00:00Z